Clinical Trial Update: Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

This Phase 3 study compares irinotecan with and without oxaliplatin in metastatic colorectal cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED